{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:53:41Z","timestamp":1744869221867},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,30]]},"DOI":"10.7759\/cureus.34367","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T09:55:25Z","timestamp":1675072525000},"source":"Crossref","is-referenced-by-count":2,"title":["Iatrogenic Cushing\u2019s Syndrome: The Result of Cobicistat and Glucocorticoid Interaction in an HIV Patient After Bariatric Surgery"],"prefix":"10.7759","author":[{"given":"V\u00e2nia","family":"Benido Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Esteves Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong Y","year":"2019","unstructured":"Gong Y, Haque S, Chowdhury P, et al.. Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment. Expert Opin Drug Metab Toxicol. 2019, 15:417-27. 10.1080\/17425255.2019.1604685","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-5-412","article-title":"Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies","volume":"16","author":"Elliot ER","year":"2016","unstructured":"Elliot ER, Theodoraki A, Jain LR, Marshall NJ, Boffito M, Baldeweg SE, Waters LJ. Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies. Clin Med (Lond). 2016, 16:412-8. 10.7861\/clinmedicine.16-5-412","journal-title":"Clin Med (Lond)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30451-5","article-title":"Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis","volume":"6","author":"Bigna JJ","year":"2018","unstructured":"Bigna JJ, Kenne AM, Asangbeh SL, Sibetcheu AT. Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis. Lancet Glob Health. 2018, 6:e193-202. 10.1016\/S2214-109X(17)30451-5","journal-title":"Lancet Glob Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232977","article-title":"The effect of HIV status on the frequency and severity of acute respiratory illness","volume":"15","author":"Brown J","year":"2020","unstructured":"Brown J, Pickett E, Smith C, et al.. The effect of HIV status on the frequency and severity of acute respiratory illness. PLoS One. 2020, 15:e0232977. 10.1371\/journal.pone.0232977","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1484","article-title":"Preventing Cushing: iatrogenic Cushing syndrome due to ritonavir-fluticasone interaction","volume":"9","author":"Tiruneh F","year":"2017","unstructured":"Tiruneh F, Awan A, Didana A, Doshi S. Preventing Cushing: iatrogenic Cushing syndrome due to ritonavir-fluticasone interaction. Cureus. 2017, 9:e1484. 10.7759\/cureus.1484","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12039","article-title":"Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management","volume":"14","author":"Saberi P","year":"2013","unstructured":"Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013, 14:519-29. 10.1111\/hiv.12039","journal-title":"HIV Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz324","article-title":"Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database","volume":"74","author":"Peyro-Saint-Paul L","year":"2019","unstructured":"Peyro-Saint-Paul L, Besnier P, Demessine L, et al.. Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database. J Antimicrob Chemother. 2019, 74:3291-4. 10.1093\/jac\/dkz324","journal-title":"J Antimicrob Chemother"},{"key":"ref8","article-title":"Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat","volume":"27","author":"Monge E","year":"2019","unstructured":"Monge E, Valeria C, Giacomelli A. Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat. Infez Med. 2019, 27:445-8.","journal-title":"Infez Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S254461","article-title":"Iatrogenic Cushing\u2019s syndrome following intra-articular triamcinolone injection in an HIV-infected patient on cobicistat presenting as a pulmonary embolism: case report and literature review","volume":"13","author":"Alidoost M","year":"2020","unstructured":"Alidoost M, Conte GA, Agarwal K, Carson MP, Lann D, Marchesani D. Iatrogenic Cushing\u2019s syndrome following intra-articular triamcinolone injection in an HIV-infected patient on cobicistat presenting as a pulmonary embolism: case report and literature review. Int Med Case Rep J. 2020, 13:229-35. 10.2147\/IMCRJ.S254461","journal-title":"Int Med Case Rep J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2019.040","article-title":"Iatrogenic Cushing's syndrome with inhaled fluticasone","volume":"42","author":"Ledger T","year":"2019","unstructured":"Ledger T, Tong W, Rimmer J. Iatrogenic Cushing's syndrome with inhaled fluticasone. Aust Prescr. 2019, 42:139-40. 10.18773\/austprescr.2019.040","journal-title":"Aust Prescr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hivar.2016.03.002","article-title":"Exogenous Cushing's syndrome as a result of ritonavir-budesonide interaction - a case report","volume":"15","author":"Pereira MT","year":"2016","unstructured":"Pereira MT, Ferreira L, Horta AA, de Carvalho AC. Exogenous Cushing's syndrome as a result of ritonavir-budesonide interaction - a case report. HIV AIDS Rev. 2016, 15:91-3. 10.1016\/j.hivar.2016.03.002","journal-title":"HIV AIDS Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.16.1903","article-title":"Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults","volume":"159","author":"Brus R","year":"1999","unstructured":"Brus R. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. Arch Intern Med. 1999, 159:1903-8. 10.1001\/archinte.159.16.1903","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000462","article-title":"A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops","volume":"28","author":"Lewis J","year":"2014","unstructured":"Lewis J, Turtle L, Khoo S, Nsutebu EN. A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops. AIDS. 2014, 28:2636-7. 10.1097\/QAD.0000000000000462","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery","volume":"33","author":"Eisenberg D","year":"2023","unstructured":"Eisenberg D, Shikora SA, Aarts E, et al.. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023, 33:3-14. 10.1007\/s11695-022-06332-1","journal-title":"Obes Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0972-9941.183481","article-title":"Comparison of weight loss outcomes 1 year after sleeve gastrectomy and Roux-en-Y gastric bypass in patients aged above 50 years","volume":"12","author":"Praveenraj P","year":"2016","unstructured":"Praveenraj P, Gomes RM, Kumar S, et al.. Comparison of weight loss outcomes 1 year after sleeve gastrectomy and Roux-en-Y gastric bypass in patients aged above 50 years. J Minim Access Surg. 2016, 12:220-5. 10.4103\/0972-9941.183481","journal-title":"J Minim Access Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31829260d6","article-title":"Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone","volume":"63","author":"Boyd SD","year":"2013","unstructured":"Boyd SD, Hadigan C, McManus M, et al.. Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone. J Acquir Immune Defic Syndr. 2013, 63:355-61. 10.1097\/QAI.0b013e31829260d6","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods CP","year":"2015","unstructured":"Woods CP, Argese N, Chapman M, et al.. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015, 173:633-42. 10.1530\/EJE-15-0608","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134896-iatrogenic-cushings-syndrome-the-result-of-cobicistat-and-glucocorticoid-interaction-in-an-hiv-patient-after-bariatric-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:28Z","timestamp":1707508168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134896-iatrogenic-cushings-syndrome-the-result-of-cobicistat-and-glucocorticoid-interaction-in-an-hiv-patient-after-bariatric-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.34367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}